Latest Breaking News On - Quantum genomics - Page 1 : vimarsana.com

Left Appendage Occlusion Device Market Closing the Gap on Stroke

Press release - InsightAce Analytic Pvt.Ltd - Left Appendage Occlusion Device Market Closing the Gap on Stroke Risk: The Left Atrial Appendage Occlusion Device - published on openPR.com

Top companiesLeft ventricular dysfunctionLeft ventricularQuantum genomics

Genetic Variant in Black Americans Linked to Heart Disease Risk

Genetic Variant in Black Americans Linked to Heart Disease Risk
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesSvatih shahBrian claggettSenthil selvarajRobertj mentzSadiyas khanJoanne mansonThomash mosleyEmilyb levitanBernhard haringCharlesb eatonRichardk chengMarianna fontanaEdwardd frohlichSanofi pasteurParag goyal

Common Genetic Variant Ups Cardiovascular Risk in Black Americans

Common Genetic Variant Ups Cardiovascular Risk in Black Americans
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesSenthil selvarajBrian claggettRichardk chengBernhard haringSanofi pasteurThomash mosleySadiyas khanEdwardd frohlichPankaj aroraRobertj mentzJoanne mansonCharlesb eatonSvatih shahMichelg khouriParag goyal

Cardiovascular Burden of the V142I Transthyretin Variant | Genetics and Genomics | JAMA

Cardiovascular Burden of the V142I Transthyretin Variant | Genetics and Genomics | JAMA
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesUnited kingdomBridgebio pharmaDaiichi sankyoBoehringer ingelheim lillySanofi pasteurBoehringer ingelheimUs department of healthAmerican heart associationMerck sharp dohmeBroad institute of harvardFoundation for sarcoidosis researchBlood instituteDoris duke foundationHuman services

Quantum Genomics : Quantum Genomics announces that it has obtained the approval of Shareholders on the reduction of its share capital and on the contribution in kind of 100% of ExactCure's securities.

The Quantum Genomics Company announces that, as part of its merger project with Exactcure, French HealthTech developing artificial intelligence software to adapt medication intake to the profile.

France generalQuantum genomics company euronext growthQuantum genomics companyEuronext growthFrench healthtechGeneral meetingJoint general meetingQuantum genomicsGeneral assembly